Invitrogen SuperScript IV First-Strand Synthesis System
Optimized for synthesis of first-strand cDNA from purified poly(A)+ or total RNA.
Manufacturer: Invitrogen 18091050
Optimized for synthesis of first-strand cDNA from purified poly(A)+ or total RNA.The kit includes SuperScript IV Reverse Transcriptase (RT), a proprietary MMLV mutant that produces robust and reliable cDNA synthesis in RT reactions. The SuperScript IV synthesis system is significantly improved over the SuperScript III-based system in inhibitor resistance, processivity, and reaction speed, while retaining all the benefits of the previous system, including increased thermostability, highly efficient full-length cDNA synthesis, and reduced RNase activity. The SuperScript IV system is designed to provide reliable, consistent, and fast cDNA synthesis in the presence of inhibitors found in a wide variety of samples that cause other currently available RTs to perform inefficiently.
The SuperScript IV First-Strand Synthesis System contains all components needed for RT reactions, plus an additional control gene and primers, and provides the flexibility to customize the RT set-up to fit the needs of your application. The SuperScript IV synthesis system is the top choice for performance and flexibility for RT-PCR applications. We recommend it for all RT-PCR applications, especially when reproducibility and reliability is the primary concern and when inhibitors in the RNA sample may interfere with cDNA synthesis, leading to biases in gene expression studies.
Features of the SuperScript IV First-Strand Synthesis System include:
- Significantly improved resistance to a variety of inhibitors that can interfere with cDNA synthesis
- Robust and specific cDNA synthesis in a wide range of sample types
- A faster reverse transcriptase reaction that reduces incubation time from >50 min to 10 min
- Significantly better processivity compared to SuperScript III RT
Purified from E. coli expressing the pol gene of M-MLV, modified to increase thermostability and half-life, processivity, inhibitor resistance and to reduce RNase H activity.
Performance and quality testing
Endodeoxyribonuclease, exodeoxyribonuclease, and ribonuclease assays; and yield and length of cDNA product.
One unit of SuperScript IV RT is the amount of enzyme required to incorporate 1 nmole of deoxyribonucleotide into acid-precipitable material in 10 min at 37°C using poly(A) oligo(dT)12-18 as a template/primer.
Unit reaction conditions
50 mM Tris-HCl (pH 8.3), 4 mM MgCl2, 10 mM DTT, 50 mM KCl, 0.5 mM dTTP, 0.4 MBq/mL [3H]-dTTP, 0.4 mM poly(A) oligo (dT)12-18 and enzyme in 20 µL for 10 min at 37°C.
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
|Oligo(dT)20 (50 μM), 50 μL; Random hexamers (50 ng/μL), 250 μL; 5X RT buffer, 1 mL0.1 M DTT, 250 μL; 10 mM dNTP mix, 250 μLSuperScript™ IV RT (10,000 units total at 200 U/μl), 50 μL; RNaseOUT™ (40 U/μL), 100 μL; E. coli RNase H (2 U/μL), 50 μL; DEPC-treated water, 1.2 mL; Total HeLa RNA (10 ng/μL), 20 μL; Sense Control Primer (10 μM), 25 μL; Antisense Control Primer (10 μM), 25 μL|
|12.3 kb or less|
|All components stored at -5 to -30°C.|
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok
For Research Use Only. Not for use in diagnostic procedures.